Loading…
Trends in the initial management of vestibular schwannoma in the United States
•This national analysis examines the care of patients with vestibular schwannoma.•28,446 patients with vestibular schwannoma were evaluated.•Age, location, payer, and facility type are factors that influence initial treatment. Vestibular schwannomas are benign tumors of the 8th cranial nerve. Initia...
Saved in:
Published in: | Journal of clinical neuroscience 2019-10, Vol.68, p.174-178 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •This national analysis examines the care of patients with vestibular schwannoma.•28,446 patients with vestibular schwannoma were evaluated.•Age, location, payer, and facility type are factors that influence initial treatment.
Vestibular schwannomas are benign tumors of the 8th cranial nerve. Initial treatment options include active surveillance, surgery, and/or radiation therapy. We analyzed the United States National Cancer Database (NCDB) for patients with vestibular schwannomas and evaluated the initial management trends after diagnosis.
We queried the NCDB for patients with vestibular schwannomas, excluding patients who did not have schwannomas of the vestibulocochlear nerve. Categorical and continuous variables were analyzed, and multivariate Cox regression analyses were performed to investigate for predictors of initial local therapy at diagnosis. All statistical analyses were performed using commercially available software (SPSS, Version 22; SPSS Inc., Chicago, IL).
A total of 28,446 patients met the inclusion criteria. In this cohort, 7351 (25.8%) underwent observation, 12,362 (43.5%) underwent surgical resection, 7785 (27.4%) underwent SRS, 824 (2.9%) underwent EBRT, and 124 (0.4%) underwent RT NOS. On multivariate analysis, younger age, increased distance to treating facility, Charlson/Deyo score of 1, primary payer insurance, facility location and facility type (academic or cancer center) (p |
---|---|
ISSN: | 0967-5868 1532-2653 |
DOI: | 10.1016/j.jocn.2019.07.002 |